PTPRC and neoplasm: To determine how DR impacts immune cells in the TME, we performed cellular indexing of transcriptomes and epitopes coupled to next-generation sequencing (CITE-seq) on live CD45+ cells sorted from B16 tumours from AL-fed or DR-fed mice.